Mass drug treatment for lymphatic filariasis and onchocerciasis.
Identifieur interne : 008E49 ( Main/Exploration ); précédent : 008E48; suivant : 008E50Mass drug treatment for lymphatic filariasis and onchocerciasis.
Auteurs : David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. TaylorSource :
- Trends in parasitology [ 1471-4922 ] ; 2003.
Descripteurs français
- KwdFr :
- Afrique, Albendazole (pharmacologie), Albendazole (usage thérapeutique), Animaux, Filaricides (pharmacologie), Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (pharmacologie), Ivermectine (usage thérapeutique), Maladies endémiques (), Onchocercose (), Onchocercose (traitement médicamenteux), Résistance aux substances, Évaluation préclinique de médicament.
- MESH :
- pharmacologie : Albendazole, Filaricides, Ivermectine.
- traitement médicamenteux : Filariose lymphatique, Onchocercose.
- usage thérapeutique : Albendazole, Filaricides, Ivermectine.
- Afrique, Animaux, Filariose lymphatique, Humains, Maladies endémiques, Onchocercose, Résistance aux substances, Évaluation préclinique de médicament.
English descriptors
- KwdEn :
- Africa, Albendazole (pharmacology), Albendazole (therapeutic use), Animals, Drug Evaluation, Preclinical, Drug Resistance, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (prevention & control), Endemic Diseases (prevention & control), Filaricides (pharmacology), Filaricides (therapeutic use), Humans, Ivermectin (pharmacology), Ivermectin (therapeutic use), Onchocerciasis (drug therapy), Onchocerciasis (prevention & control).
- MESH :
- chemical , pharmacology : Albendazole, Filaricides, Ivermectin.
- chemical , therapeutic use : Albendazole, Filaricides, Ivermectin.
- geographic : Africa.
- drug therapy : Elephantiasis, Filarial, Onchocerciasis.
- prevention & control : Elephantiasis, Filarial, Endemic Diseases, Onchocerciasis.
- Animals, Drug Evaluation, Preclinical, Drug Resistance, Humans.
PubMed: 14580963
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004144
- to stream PubMed, to step Curation: 004144
- to stream PubMed, to step Checkpoint: 004144
- to stream Ncbi, to step Merge: 001731
- to stream Ncbi, to step Curation: 001731
- to stream Ncbi, to step Checkpoint: 001731
- to stream Main, to step Merge: 009132
- to stream Main, to step Curation: 008E49
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mass drug treatment for lymphatic filariasis and onchocerciasis.</title>
<author><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name>
<affiliation wicri:level="1"><nlm:affiliation>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. fahy@liv.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA</wicri:regionArea>
<wicri:noRegion>Liverpool L3 5QA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name>
</author>
<author><name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
</author>
<author><name sortKey="Kyelem, Dominique" sort="Kyelem, Dominique" uniqKey="Kyelem D" first="Dominique" last="Kyelem">Dominique Kyelem</name>
</author>
<author><name sortKey="Taylor, Mark J" sort="Taylor, Mark J" uniqKey="Taylor M" first="Mark J" last="Taylor">Mark J. Taylor</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14580963</idno>
<idno type="pmid">14580963</idno>
<idno type="wicri:Area/PubMed/Corpus">004144</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004144</idno>
<idno type="wicri:Area/PubMed/Curation">004144</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004144</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004144</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004144</idno>
<idno type="wicri:Area/Ncbi/Merge">001731</idno>
<idno type="wicri:Area/Ncbi/Curation">001731</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001731</idno>
<idno type="wicri:doubleKey">1471-4922:2003:Molyneux D:mass:drug:treatment</idno>
<idno type="wicri:Area/Main/Merge">009132</idno>
<idno type="wicri:Area/Main/Curation">008E49</idno>
<idno type="wicri:Area/Main/Exploration">008E49</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Mass drug treatment for lymphatic filariasis and onchocerciasis.</title>
<author><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name>
<affiliation wicri:level="1"><nlm:affiliation>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. fahy@liv.ac.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA</wicri:regionArea>
<wicri:noRegion>Liverpool L3 5QA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name>
</author>
<author><name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
</author>
<author><name sortKey="Kyelem, Dominique" sort="Kyelem, Dominique" uniqKey="Kyelem D" first="Dominique" last="Kyelem">Dominique Kyelem</name>
</author>
<author><name sortKey="Taylor, Mark J" sort="Taylor, Mark J" uniqKey="Taylor M" first="Mark J" last="Taylor">Mark J. Taylor</name>
</author>
</analytic>
<series><title level="j">Trends in parasitology</title>
<idno type="ISSN">1471-4922</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa</term>
<term>Albendazole (pharmacology)</term>
<term>Albendazole (therapeutic use)</term>
<term>Animals</term>
<term>Drug Evaluation, Preclinical</term>
<term>Drug Resistance</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Endemic Diseases (prevention & control)</term>
<term>Filaricides (pharmacology)</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>Ivermectin (pharmacology)</term>
<term>Ivermectin (therapeutic use)</term>
<term>Onchocerciasis (drug therapy)</term>
<term>Onchocerciasis (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Afrique</term>
<term>Albendazole (pharmacologie)</term>
<term>Albendazole (usage thérapeutique)</term>
<term>Animaux</term>
<term>Filaricides (pharmacologie)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Ivermectine (pharmacologie)</term>
<term>Ivermectine (usage thérapeutique)</term>
<term>Maladies endémiques ()</term>
<term>Onchocercose ()</term>
<term>Onchocercose (traitement médicamenteux)</term>
<term>Résistance aux substances</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Albendazole</term>
<term>Filaricides</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term>
<term>Filaricides</term>
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Albendazole</term>
<term>Filaricides</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Endemic Diseases</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Onchocercose</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term>
<term>Filaricides</term>
<term>Ivermectine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Drug Evaluation, Preclinical</term>
<term>Drug Resistance</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Afrique</term>
<term>Animaux</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Maladies endémiques</term>
<term>Onchocercose</term>
<term>Résistance aux substances</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><noCountry><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name>
<name sortKey="Hoerauf, Achim" sort="Hoerauf, Achim" uniqKey="Hoerauf A" first="Achim" last="Hoerauf">Achim Hoerauf</name>
<name sortKey="Kyelem, Dominique" sort="Kyelem, Dominique" uniqKey="Kyelem D" first="Dominique" last="Kyelem">Dominique Kyelem</name>
<name sortKey="Taylor, Mark J" sort="Taylor, Mark J" uniqKey="Taylor M" first="Mark J" last="Taylor">Mark J. Taylor</name>
</noCountry>
<country name="Royaume-Uni"><noRegion><name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008E49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008E49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:14580963 |texte= Mass drug treatment for lymphatic filariasis and onchocerciasis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:14580963" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |